Quality Assurance & Regulatory Affairs
Quality is part of every step of the development process; from initial discussions with the client before the start of a project to discussions and support after product delivery.
This includes recognition of Quality when generating a quote, confirming an order, designing the most suitable manufacturing process, controlling product quality at each production step, informing clients in a timely fashion, conducting finished product testing, generating the Certificate of Analysis (CoA) and releasing the final product.
Quality continues after product release, when conducting stability, and assisting clients with regulatory filing.
Because quality is not a coincidence.
Our Core Values
INNOVATION
- We are curious and explore new ways.
- We are also ambitious and find solutions.
EXCELLENCE
- We have a strong technical knowledge, and we deliver results
- We lead quality in everything we do
- We are adaptable and customer focused
TRUST
- We believe in teamwork and collaboration.
- We lead by example and accept responsibility
- We are transparent and we show integrity.
About PolyPeptide Group
PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.
PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide Group AG’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.